Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Roundabout homolog 1 receptor (ROBO1) is a transmembrane protein encoded by the *ROBO1* gene. It belongs to the immunoglobulin superfamily and functions primarily as an axon guidance receptor that mediates cellular responses to molecular cues—most notably through binding SLIT family ligands—to regulate neuronal navigation across the midline during central nervous system development. In addition to its critical role in neural patterning and cell adhesion, ROBO1 has been implicated in regulating cell proliferation and migration outside of neural tissues. Clinically, genetic variants or disruptions of *ROBO1* have been associated with neurodevelopmental disorders such as dyslexia and may influence susceptibility to certain cancers through pathways affecting cellular growth control[1][2][3][5].
(There are no approved drugs targeting this molecule; however, experimental modulation would likely involve altering axon guidance or cell migration by interfering with Slit–ROBO signaling.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Roundabout homolog 1 receptor (ROBO1).